The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Kabiven emulsion for infusion


Emulsion for infusion


Fresenius Kabi Deutschland GmbHPA2059/045/003

Main Information

Trade NameKabiven emulsion for infusion
Active SubstancesSoya bean oil
Glucose monohydrate
Alanine
Arginine
Aspartic Acid
Glutamic acid
Glycine
Histidine
Isoleucine
Leucine
Lysine Hydrochloride
Methionine
Phenylalanine
Proline
Serine
Threonine
Tryptophan
Tyrosine
Valine
Calcium Chloride 2 H2O
Sodium glycerophosphate anhydrous
Magnesium sulphate 7h2o
Potassium chloride
Sodium acetate 3 H20
Amino acids
Nitrogen
Fat
Glucose
Glucose (dextrose)
Sodium
Potassium
Magnesium
Calcium
Phosphate
Sulphate
Chloride
Acetate
Strength
Dosage FormEmulsion for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/045/003

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA10 combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued28/07/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back